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 Sepsis is a common condition with high morbidity and 
mortality. Although many patients may require critical care, 
this article considers the features of sepsis that are of most 
relevance to acute general physicians. Recently updated 
definitions of sepsis and septic shock have been proposed 
which better identify patients who are likely to have a poor 
outcome, and therefore give an opportunity to escalate care. 
Despite these advances, there is still no molecular signature 
able to diagnose sepsis. Pathogenesis is complex, with many 
immune and non-immune mediators involved. Four key areas 
are endothelial dysfunction, coagulation abnormalities, 
alterations in cell function and dysregulated cardiovascular 
responses. No specific therapy targeting the mediators of 
sepsis has yet proven effective. Prompt administration of 
appropriate antibiotics is of benefit, together with fluid 
resuscitation and oxygen. 
 Introduction 
 Sepsis derives from the Greek for putrefaction and was recognised 
as a frequent complication of wounds. As will be discussed here, 
the definitions of sepsis still prove difficult, and despite significant 
advances in intensive care medicine and antimicrobial therapy, 
sepsis remains a common condition with high attributable 
mortality. The most seriously affected by sepsis will require 
management in an intensive care setting where available, but this 
article will focus on the diagnosis and immediate management of 
sepsis, as this is of broad importance to all physicians dealing with 
acutely ill patients. 
 Defi nition 
 Septicaemia, blood poisoning and other vague terminology, 
meaning different things to different people, were used frequently. 
This hampered attempts to properly identify septic patients 
promptly, and hindered the design of trials with standardised entry 
criteria. In 1991, a consensus conference developed definitions of 
sepsis that linked infection with a systemic inflammatory response, 
the systemic inflammatory response syndrome (SIRS), which was 
defined using simple clinical and laboratory parameters. 1,2 This 
had the advantage of standardising the definition of sepsis across 
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 KEYWORDS :  sepsis ,  infection ,  critical care ■ 
different regions and was a significant advance. However, the 
definition of SIRS, although sensitive to detect sepsis, was rather 
unspecific, since similar inflammatory responses were seen as part 
of the physiological response to non-infectious insults, such as 
surgery and pancreatitis. In addition, the SIRS criteria performed 
badly in identifying patients who required critical care and who 
had significant morbidity and mortality. 3 
 These issues led to a recent new consensus definition for sepsis 
and septic shock. 4–6 This international task force defined sepsis as 
‘life-threatening organ dysfunction caused by a dysregulated host 
response to infection.’ Importantly, the task force considered how 
to operationalise this definition, by analysing what clinical criteria 
best identified infected patients with sepsis who died. Using large 
datasets (>1 million patient records), they found that an increase 
in 2 points or more for a patient suspected to have infection 
using the Sequential Organ Failure Assessment (SOFA) best 
predicted in-hospital mortality. 6 The SOFA is well known within 
the intensive care community, but is not so well known generally. 
Therefore, the task force developed a simpler clinical screening 
tool that performed very well in identifying adult patients with 
suspected infection who were likely to have poor outcomes, which 
they termed ‘quick SOFA’ (qSOFA). This measures three clinical 
parameters ( Box 1 ). 
 A patient who fulfilled two of these criteria had similar outcomes 
to those who had an increase in 2 points on the full SOFA scale. 
The task force therefore considered that a qSOFA score of 2 or 
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more should prompt clinicians to investigate further for organ 
dysfunction, consider escalation of therapy, and evaluate for 
referral to critical care. 
 The same grouping also considered the definitions of septic 
shock. Traditionally, this had been defined based on the cardinal 
feature of hypotension as a marker of the cardiovascular 
dysfunction associated with this condition. However, it has 
become apparent that the application and interpretation of such a 
definition is very variable. Therefore, a new consensus was sought. 
Septic shock was newly defined as ‘a subset of sepsis in which 
circulatory, cellular and metabolic abnormalities are associated 
with a greater risk of mortality than sepsis alone.’ 5 Operationally, 
they identified septic shock as being present when the two 
particular conditions were met ( Box 2 ). 
 These new definitions have been adopted by numerous 
international societies but are only just entering into routine 
clinical practice. They have the advantage of simplicity and are 
underpinned by robust data on their performance in identifying 
those patients with suspected infection who have the worst 
outcomes. They are simpler to apply, for example, than the 
recent National Institute for Health and Care Excellence (NICE) 
guidelines. 7 However, a number of problems remain. This 
consensus group did not address the definition of infection. 
Despite improvements in diagnosis, only about 30–40% of 
patients who are suspected of having an infection will actually 
have a positive microbiological diagnosis. 8 Therefore, patients 
whose organ dysfunction is secondary to a cause other than 
infection will still potentially be misdiagnosed and unnecessary 
antimicrobials administered. Additionally, no stratification of 
different degrees of sepsis is given, so targeting care for individual 
patients is difficult. In other fields, such as cancer biology, a wealth 
of genetic, transcriptomic and metabolic data are allowing ever 
more specific ‘personalised’ treatment. Despite many excellent 
studies, there is as yet no molecular ‘signature’ of particular 
biomarkers that can unequivocally identify a patient with infection 
or their likely outcome. Such objective molecular criteria would 
greatly help in diagnosis and management. 
 Pathogenesis 
 The pathogenesis of sepsis is complex 9,10 and due to the 
constraints of space, only a summary can be given here. A key 
conceptual advance was made in a seminal paper in 1986 which 
showed that the host cytokine tumour necrosis factor (TNF, also 
known as cachectin) could reproduce many of the pathological 
and clinical features of sepsis. 11 Given that many bacterial and 
other pathogen products can induce TNF production, it was clear 
that the host response to infection played an important role 
in the pathogenesis of the condition, as originally observed by 
Lewis Thomas in 1972. Since then, numerous studies have shown 
a complex network of cytokines are important in mediating 
many of the effects of sepsis. Moreover, although initial 
proinflammatory pathways are important, anti-inflammatory 
pathways are also activated and can downregulate corrective 
responses later in the course of sepsis. In addition to protein and 
peptide mediators, there are also a plethora of other mediators 
involved, including prostanoids, platelet activating factor, and 
endogenous damage-associated molecular patterns (DAMPS) 
released from injured cells, such as ATP and high mobility group 
proteins. 
 In an attempt to simplify this complex pathogenic pathway, 
four main features can be highlighted – the four horsemen of the 
septic apocalypse (Fig 1). 
 >  Endothelial dysfunction 
 Generalised endothelial activation increases the expression 
of a number of leucocyte adhesins, with increased leucocyte 
transmigration into tissues. The permeability of the endothelium is 
also increased, in the lung leading to interstitial pulmonary edema 
and in the gut increasing bacterial translocation, potentially 
exacerbating the inflammatory cascades already initiated by 
microbial products. 
 >  Coagulopathy 
 Altered coagulation is extremely common in sepsis. Endothelial 
damage removes the protective function of the natural 
anticoagulation protein C pathway and converts the endothelium 
into a prothrombotic surface. In addition, bacterial products and 
inflammatory cytokines activate tissue factor, the main initiator 
of the extrinsic pathway of blood coagulation. This prothrombotic 
state may lead to blockage of the microvasculature, as well 
as giving rise to a consumption coagulopathy (disseminated 
intravascular coagulation). Gram-positive products can also 
directly activate the contact clotting system. 
 >  Cellular dysfunction 
 One of the enigmas of the field is that even in the most severe 
cases of lethal sepsis, autopsy studies show little evidence of cell 
death, despite widespread organ dysfunction. The molecular 
basis of this is still not clear, although a generalised reduction in 
energy expenditure by cells suggests some kind of hibernation-
like process. Concomitant with this alteration in cellular function 
are numerous metabolic changes, notably increased catabolism, 
insulin resistance and hyperglycaemia. 
 >  Cardiovascular dysfunction 
 Many studies have shown that patients with sepsis have a 
decreased systemic vascular resistance (SVR) with a normal or 
increased cardiac output, the so-called ‘hyperdynamic’ state 
of sepsis. Cardiac output is maintained at the expense of left 
ventricular dilation, with reduced ejection fraction and a reduced 
left ventricular stroke work index in response to left ventricular 
end diastolic volume increase. These changes can lead to the 
hypotension characterising septic shock. Changes in SVR are 
probably largely mediated by excess production of the vasodilator 
nitric oxide in the vasculature, 12 which can be difficult to correct 
with vasopressors. Poor tissue perfusion also likely underlies the 
increased lactate seen in septic shock, although other mechanisms 
are possible. 
 Box 1.  qSOFA criteria 
> Respiratory rate ≥22/min
> Glasgow Coma Scale <15
> Systolic blood pressure ≤100 mmHg
 Box 2.  Criteria for septic shock 
>  A need for vasopressor therapy to maintain a mean arterial 
pressure ≥65 mmHg
>  A serum lactate >2 mM, persisting after adequate fluid 
resuscitation
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 Management 
 Survival in sepsis has improved over the last 40 years. However, we 
still lack a specific molecular therapy for this condition, other than 
antimicrobial therapy. Numerous trials of promising biological 
agents targeting different mediators of sepsis have failed. This 
article will focus on the immediate management of sepsis – the 
management of patients in a critical care setting is not covered 
here. 
 >  Resuscitation 
 Immediate resuscitation of a critically ill septic patient is not 
appreciably different from non-septic patients. Adequate oxygen 
to maintain saturations in excess of 95% should be given. 
Although there is no high quality randomised controlled trial 
evidence, it is considered standard care to give intravenous saline 
to all patients with sepsis. 13 For patients with hypotension, this 
should be a bolus of 500 mL of saline over 15 minutes. Further 
fluids should be titrated to response. Starch based fluids should be 
avoided 14 and there is no evidence to support the use of albumin. 15 
Persistent hypotension despite adequate fluid resuscitation will 
almost certainly require admission to a critical care facility and the 
use of vasopressors – noradrenaline is the preferred agent. 16 
 >  Prompt and appropriate antimicrobial therapy 
 Studies have shown a clear benefit of rapid use of antimicrobials 
that target the likely causative pathogens. 17 Although the exact 
timing required is not entirely clear, every effort should be made 
to give such drugs as quickly as possible, ideally within 1 hour 
of admission. Prior to administering antibiotics, blood cultures 
should be taken. Although there are no trials showing the benefit 
or not of such cultures, identification and characterisation of 
 Table 1.  Summary of different guidelines for the management of sepsis 
Origin Website Focus
 Sepsis Trust  https://sepsistrust.org/education/clinical-tools/ UK-based charity and originator of the ‘Sepsis 
six’
Produced in collaboration with NICE
 National Institute for Health and 
Care Excellence (NICE) guidelines 
 www.nice.org.uk/guidance/ng51 Comprehensive though complex algorithms
Published before new sepsis definitions
Royal College of Physicians  www.rcplondon.ac.uk/guidelines-policy/acute-
care-toolkit-9-sepsis 
Distillation of NICE guidance and again uses 
older definitions
Royal College of Emergency 
Medicine
 www.rcem.ac.uk/docs/Clinical%20Standards%20
and%20Guidance/Clinical%20Standards%20
for%20Emergency%20Departments.pdf 
Based on Sepsis Trust guidelines Tailored to 
emergency department use
Surviving sepsis campaign  www.survivingsepsis.org/Bundles/Pages/
default.aspx 
The most up to date and useful of the 
guidelines, using the new (2016) definitions 
of sepsis
 Fig 1.  The key pathophysiological changes of sepsis 
and how these combine to produce multiorgan 
failure. 
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antibiotic sensitivities of cultured pathogens is crucial in further 
management. 
 >  Accurate fluid balance 
 Urine output should be recorded, together with all fluids 
administered. A urinary catheter should be placed if required for 
patient management but it is not essential. 
 >  Blood glucose 
 In the event of hyperglycaemia, blood sugar should be kept 
<10 mM with intravenous insulin. More aggressive blood sugar 
control is contraindicated. 18 
 >  Source control 
 Notwithstanding the need for immediate attention to the 
deranged physiological parameters, identification and 
management of the source of sepsis is also important. From 
the history, full examination and appropriate radiological 
investigations, a likely source of infection may be identified; 
although, in around 25% of cases no source can be identified. 
However, prompt management of an infection source is vital, such 
as drainage of a pleural effusion, debridement of an infected 
wound, or surgical intervention to drain an intra-abdominal 
abscess. 
 A variety of care bundles to streamline the delivery of such care 
have been evaluated, see  Table 1 . In the UK, the ‘Sepsis six’ has 
been developed and adopted by the Sepsis Trust. 19 It is a useful 
way of ensuring key steps in management are not forgotten and 
is widely used in UK hospitals. The most up-to-date guidelines are 
those published by the Surviving Sepsis Campaign. 20 
 Despite an initial trial suggesting that early goal-directed 
therapy could reduce the mortality from septic shock, recent trials 
have not supported any benefit from such goal-directed therapy 
compared to standard care. 21 ■ 
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